The aim is to investigate sex-based differences in muscle pathology after musculoskeletal injury.
Conducted multi-omics analysis to assess muscle samples
Compared muscle pathology between sexes
Analyzed data for sex-specific differences in treatment needs
Identified distinct muscle weakness patterns in males and females
Detected specific biochemical markers differing by sex
Outlined implications for personalized clinical interventions based on sex differences
Abstract
These findings reveal inherent sex-based differences in muscle pathology that likely necessitate unique clinical treatments following musculoskeletal injury.